New Drug Pricing Bill from House Democrat Leadership Threatens to Short-Circuit California Biomedical Innovation

WASHINGTON & SAN FRANCISCO & SAN DIEGO–(BUSINESS WIRE)– #DrugPricing–California Life Sciences Association (CLSA) Voices Concerns with Speaker Pelosi?s Drug Pricing Proposal